Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

MEDA Pharma is a company that provides healthcare services to people of high quality with safety. A medium-sized pharmaceutical company, Madaus GmbH belongs to the worldwide operating Meda Group. They manufacture pharmaceuticals as well as scientifically based health products such as medical devices, cosmetics, and dietary supplements. Its mission was to set new standards for health care, give 7 billion people access to high-quality medicine, and carry out research to address unmet healthcare needs.

Farmalíder is a group of Spanish companies involved in the development, registration, licensing and production of generic pharmaceutical products – specialising in pain management, as evidenced by its market leading position in the ibuprofen and paracetamol markets in Spain – with a growing presence in other European markets.

Labopharm Inc. is an international, specialty pharmaceutical company that focuses on optimizing the performance of existing drugs by incorporating its advanced controlled-release technologies.

Revogenex Ireland Ltd. is a private company headquartered in Ireland that provides research and development of natural science and engineering services.

ALZA Corp. is a pharmaceutical and medical systems company that develops, manufactures, and markets therapeutic systems. It provides oral, transdermal, implantable, and liposomal technologies. It is also focused on drug delivery systems with over 20 prescription pharmaceutical products. With over 10,000 employees, ALZA Corp. is a subsidiary of Johnson & Johnson. It was established in 1968 by Dr Alejandro Zaffaroni. It is based inVacaville, California.

Laboratorios Vita SA is a Spanish private company located in Sant Joan Despi. The firm produces and commercializes pharmaceutical products.

DMI BioSciences, Inc. manufactures pharmaceutical products. It develops diagnostic tests and drugs for the medical device and biopharmaceutical industry. The company was founded by David Bar-Or in 1990 and is headquartered in Greenwood Village, CO.

Laboratorios Menarini SA, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite SRL, is a company headquartered in Spain that manufactures and processes pharmaceutical products.

Cilag AG is an international operating company integrated in the Janssen Pharmaceutical Companies of Johnson & Johnson that provides its customers with highest quality active pharmaceutical ingredients and pharmaceutical products worldwide. To achieve this they comply with worldwide Quality, Health, Safety and Environmental standards. These standards are basically ensured by their more than 1000 well trained and developed, conscientious and highly motivated employees, who are their most valuable capital.

Nippon Zoki Pharmaceutical Co. Ltd. is a private company headquartered in Chuo-ku, Japan, that manufactures pharmaceutical products.

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Darwin Discovery Ltd., part of UCB SA, is a company headquartered in Slough, UK, providing investment services. It was founded in 1998.

e-Therapeutics Plc, is a drug discovery and development company, which engages in the provision of evaluation services to investors and pharmaceutical companies. The company focuses on the therapeutic immune-oncology, addressing drug resistance in targeted cancer therapies and antivirals. It offers the following variety of preclinical stage assets: ETS2300, telomerase inhibition in anti-cancer; ETS3100, small molecule anti-TNFa; ETS2400, Hedgehog pathway inhibition; and ETS5200, broad spectrum antivirals together with two immuno-oncology checkpoint projects. The company was founded by Malcolm Philip Young on October 15, 2001 and is headquartered in London, the United Kingdom.